Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares. The company’s ...

Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This ...

Monogram Orthopaedics Inc ( ($MGRM) ) has issued an update. On March 17, 2025, Monogram Technologies Inc. announced that it received FDA 510(k) ...

Analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a ...

AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI ...

Stock analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The ...

Monogram Orthopaedics Inc. (MGRM) ended its fourth quarter of 2024 with a cash balance of $15.7 million, bolstered by a successful $13 million fundraising round. The company, which is developing ...

Monogram Orthopaedics Inc. (MGRM) ended its fourth quarter of 2024 with a cash balance of $15.7 million, bolstered by a successful $13 million fundraising round. The company, which is developing an ...

MONOGRAM ORTHOPAEDICS ($MGRM) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of -$0.08 per share, beating estimates of -$0. ...

AUSTIN, TX - Monogram Technologies Inc. (NASDAQ:MGRM), a micro-cap medical technology company valued at approximately $80 million specializing in AI-driven robotics for orthopedic surgery ...